Announce Date | 05/01/2025 |
EPS Normalized Actual | $-0.47 (Beat by $0.08) |
EPS GAAP Actual | $-0.47 (Beat by $0.08) |
Revenue Actual | $0.081732B |
Revenue Surprise | Beat by $81.732M |
Announce Date | 06/30/2025 (Pre-Market) |
EPS Normalized Estimate | $-0.39597 |
EPS GAAP Estimate | $-0.39597 |
Revenue Estimate | $0.0849352B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2029 | 4.67 | 4.4 | 3.14569 | 6.46185 | 3 |
Dec 2028 | 1.33 | 15.45 | 0.89332 | 2.10247 | 4 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ1 2025 (Mar 2025) | -0.47 | 0.14197 | 0.081732B | 49.38% | 19.9M |
FQ4 2024 (Dec 2024) | -0.73 | -0.06552 | 0.074787B | 39.75% | 17.82M |
FQ3 2024 (Sep 2024) | -0.7 | 0.06406 | 0.062898B | 41.02% | 10.03M |
FQ2 2024 (Jun 2024) | -0.91 | -2.25259 | 0.054116B | 100% | -10.8M |
FQ1 2024 (Mar 2024) | -1.76 | -1.76 | 0.041374B | 100% | 41.37M |
FQ4 2023 (Dec 2023) | -1.18 | -1.18 | 0.045059B | 100% | 45.06M |
FQ1 2010 (Feb 2010) | 0.0003 | 0.0003 | 0B | NAN% | 0M |
FQ3 2023 (Sep 2023) | 0.002 | 0.002 | 0.037095B | 100% | 37.1M |
FQ4 Announce Date
06/30/2025 (Pre-Market)
Consensus EPS Estimates
-0.39597
Consensus Revenue Estimates
0.0849352B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2026 (Dec 2026) | 1.42 | -- | 0.8684 | 2.16555 | 1 |
FQ3 2026 (Sep 2026) | 0.75 | -- | 0.45866 | 1.14378 | 1 |
FQ2 2026 (Jun 2026) | 0.42 | -- | 0.25685 | 0.64051 | 1 |
FQ1 2026 (Mar 2026) | 0.14 | 435.71 | 0.08561723 | 0.2135 | 1 |
FQ4 2025 (Oct 2025) | -0.454 | -60.79 | -0.64234 | -0.33089 | 4 |
FQ3 2025 (Jul 2025) | -0.54395 | -28.69 | -0.7696 | -0.39645 | 4 |
FQ2 2025 (Jun 2025) | -0.39597 | -129.82 | -0.54569 | -0.3098 | 5 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2026 (Dec 2026) | 0.24B | -- | 0.17B | 0.33B | 4 |
FQ3 2026 (Sep 2026) | 0.2B | -- | 0.14B | 0.28B | 4 |
FQ2 2026 (Jun 2026) | 0.17B | -- | 0.12B | 0.23B | 4 |
FQ1 2026 (Mar 2026) | 0.14B | 39.86 | 0.1B | 0.19B | 4 |
FQ4 2025 (Oct 2025) | 0.07B | -0.47 | 0.06B | 0.1B | 4 |
FQ3 2025 (Jul 2025) | 0.07B | 4.51 | 0.05B | 0.09B | 4 |
FQ2 2025 (Jun 2025) | 0.08B | 36.29 | 0.07B | 0.11B | 4 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
4
EPS # of Misses
4
EPS # of in-lines
0
Revenue # of Beats
6
Revenue # of Misses
1
Revenue # of in-lines
1
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | -0.61197 | -0.47 | 0.14197 | -30.21% |
FQ4 2024 (Dec 2024) | -0.66448 | -0.73 | -0.06552 | 8.98% |
FQ3 2024 (Sep 2024) | -0.76406 | -0.7 | 0.06406 | -9.15% |
FQ2 2024 (Jun 2024) | 1.34259 | -0.91 | -2.25259 | 247.54% |
FQ1 2024 (Mar 2024) | -1.76 | -1.76 | 100% | |
FQ4 2023 (Dec 2023) | -1.18 | -1.18 | 100% | |
FQ1 2010 (Feb 2010) | 0.0003 | 0.0003 | 100% | |
FQ3 2023 (Sep 2023) | 0.002 | 0.002 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | $0.06B | $0.08B | $19.9M | 24.35% |
FQ4 2024 (Dec 2024) | $0.06B | $0.07B | $17.82M | 23.83% |
FQ3 2024 (Sep 2024) | $0.05B | $0.06B | $10.03M | 15.94% |
FQ2 2024 (Jun 2024) | $0.06B | $0.05B | $-10.8M | -19.96% |
FQ1 2024 (Mar 2024) | $0B | $0.04B | $41.37M | 100% |
FQ4 2023 (Dec 2023) | $0B | $0.05B | $45.06M | 100% |
FQ1 2010 (Feb 2010) | $0B | $0B | $0M | NAN% |
FQ3 2023 (Sep 2023) | $0B | $0.04B | $37.1M | 100% |